Silencing LINC00663 inhibits inflammation and angiogenesis through downregulation of NR2F1 via EBF1 in bladder cancer

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi: 10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Kamat AM, Hahn NM, Efstathiou JA, et al. Bladder cancer. Lancet. 2016;388(10061):2796–2810. doi: 10.1016/S0140-6736(16)30512-8
   PubMed Web of Science ®Google Scholar
• Cumberbatch MGK, Jubber I, Black PC, et al. Epidemiology of bladder cancer: a systematic review and contemporary update of risk factors in 2018. Eur Urol. 2018;74(6):784–795. doi: 10.1016/j.eururo.2018.09.001
   PubMed Web of Science ®Google Scholar
• Murata M. Inflammation and cancer. Environ Health Prev Med. 2018;23(1):50. doi: 10.1186/s12199-018-0740-1
   PubMed Web of Science ®Google Scholar
• Wigner P, Grebowski R, Bijak M, et al. The Interplay between oxidative stress, inflammation and angiogenesis in bladder cancer development. Int J Mol Sci. 2021;22(9):22. doi: 10.3390/ijms22094483
   Web of Science ®Google Scholar
• Gouin KH 3rd, Ing N, Plummer JT, et al. An N-Cadherin 2 expressing epithelial cell subpopulation predicts response to surgery, chemotherapy and immunotherapy in bladder cancer. Nat Commun. 2021;12(1):4906. doi: 10.1038/s41467-021-25103-7
   Web of Science ®Google Scholar
• Meng J, Liu X, Tang S, et al. METTL3 inhibits inflammation of retinal pigment epithelium cells by regulating NR2F1 in an m(6)A-dependent manner. Front Immunol. 2022;13:905211. doi: 10.3389/fimmu.2022.905211
   Web of Science ®Google Scholar
• Gao XL, Zheng M, Wang HF, et al. NR2F1 contributes to cancer cell dormancy, invasion and metastasis of salivary adenoid cystic carcinoma by activating CXCL12/CXCR4 pathway. BMC Cancer. 2019;19(1):743. doi: 10.1186/s12885-019-5925-5
   Google Scholar
• Tang F, Li Z, Lai Y, et al. A 7-gene signature predicts the prognosis of patients with bladder cancer. BMC Urol. 2022;22(1):8. doi: 10.1186/s12894-022-00955-3
   Web of Science ®Google Scholar
• Simion V, Haemmig S, Feinberg MW. LncRNAs in vascular biology and disease. Vasc Pharmacol. 2019;114:145–156. doi: 10.1016/j.vph.2018.01.003
   PubMed Web of Science ®Google Scholar
• Braga EA, Fridman MV, Moscovtsev AA, et al. LncRNAs in ovarian cancer progression, metastasis, and main pathways: ceRNA and alternative mechanisms. Int J Mol Sci. 2020;21(22):21. doi: 10.3390/ijms21228855
   Web of Science ®Google Scholar
• Luo H, Xu C, Le W, et al. lncRNA CASC11 promotes cancer cell proliferation in bladder cancer through miRNA-150. J Cell Biochem. 2019;120(8):13487–13493. doi: 10.1002/jcb.28622
   PubMed Web of Science ®Google Scholar
• Chen C, Luo Y, He W, et al. Exosomal long noncoding RNA LNMAT2 promotes lymphatic metastasis in bladder cancer. J Clin Invest. 2020;130(1):404–421. doi: 10.1172/JCI130892
   PubMed Web of Science ®Google Scholar
• Ke M. Identification and validation of apparent imbalanced Epi-lncRnas prognostic model based on multi-omics data in pancreatic cancer. Front Mol Biosci. 2022;9:860323. doi: 10.3389/fmolb.2022.860323
   Web of Science ®Google Scholar
• Zhu J, Wang H, Ma T, et al. Identification of immune-related genes as prognostic factors in bladder cancer. Sci Rep. 2020;10(1):19695. doi: 10.1038/s41598-020-76688-w
   Web of Science ®Google Scholar
• Liu J, Lichtenberg T, Hoadley KA, et al. An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell. 2018;173(2):400–416.e11. doi: 10.1016/j.cell.2018.02.052
   PubMed Web of Science ®Google Scholar
• Soejima M, Koda Y. TaqMan-based real-time PCR for genotyping common polymorphisms of haptoglobin (HP1 and HP2). Clin Chem. 2008;54(11):1908–1913. doi: 10.1373/clinchem.2008.113126
   PubMed Web of Science ®Google Scholar
• Sun D, Chen C, Hu W, et al. Low expression level of ASK1-interacting protein-1 correlated with tumor angiogenesis and poor survival in patients with esophageal squamous cell cancer. Onco Targets Ther. 2018;11:7699–7707. doi: 10.2147/OTT.S178131
   Web of Science ®Google Scholar
• Zhu CZ, Ting HN, Ng KH, et al. A review on the accuracy of bladder cancer detection methods. J Cancer. 2019;10(17):4038–4044. doi: 10.7150/jca.28989
   PubMed Web of Science ®Google Scholar
• Li Y, Li G, Guo X, et al. Non-coding RNA in bladder cancer. Cancer Lett. 2020;485:38–44. doi: 10.1016/j.canlet.2020.04.023
   PubMed Web of Science ®Google Scholar
• Liu J, Wu Z, Han D, et al. Mesencephalic astrocyte-derived neurotrophic factor inhibits liver cancer through small ubiquitin-related modifier (Sumo)ylation-related suppression of NF-κB/Snail signaling pathway and epithelial-mesenchymal transition. Hepatology. 2020;71(4):1262–1278. doi: 10.1002/hep.30917
   PubMed Web of Science ®Google Scholar
• Bao Z, Zeng W, Zhang D, et al. SNAIL Induces EMT and lung metastasis of tumours secreting CXCL2 to promote the invasion of M2-type immunosuppressed macrophages in colorectal cancer. Int J Biol Sci. 2022;18(7):2867–2881. doi: 10.7150/ijbs.66854
   PubMed Web of Science ®Google Scholar
• Ma X, Qi W, Yang F, et al. Deubiquitinase JOSD1 promotes tumor progression via stabilizing Snail in lung adenocarcinoma. Am J Cancer Res. 2022;12(5):2323–2336.
   Web of Science ®Google Scholar
• Zhan T, Chen M, Liu W, et al. MiR-455-3p inhibits gastric cancer progression by repressing Wnt/β-catenin signaling through binding to ARMC8. BMC Med Genomics. 2023;16(1):155. doi: 10.1186/s12920-023-01583-y
   Web of Science ®Google Scholar
• Chen L, Xie X, Wang T, et al. ARL13B promotes angiogenesis and glioma growth by activating VEGFA-VEGFR2 signaling. Neuro Oncol. 2023;25(5):871–885. doi: 10.1093/neuonc/noac245
   Web of Science ®Google Scholar
• Rubtsova SN, Zhitnyak IY, Gloushankova NA. Dual role of E-cadherin in cancer cells. Tissue Barriers. 2022;10(4):2005420. doi: 10.1080/21688370.2021.2005420
   PubMed Web of Science ®Google Scholar
• Li H, Chen J, Li Z, et al. S100A5 attenuates efficiency of anti-PD-L1/PD-1 immunotherapy by inhibiting CD8+T cell-mediated anti-cancer immunity in bladder carcinoma. Adv Sci (Weinh). 2023;10(25):e2300110. doi: 10.1002/advs.202300110
   Google Scholar
• Feng L, Yang J, Zhang W, et al. Prognostic significance and identification of basement membrane-associated lncRNA in bladder cancer. Front Oncol. 2022;12:994703. doi: 10.3389/fonc.2022.994703
   Google Scholar
• Wang X, Shojaie A, Zhang Y, et al. Exploratory plasma proteomic analysis in a randomized crossover trial of aspirin among healthy men and women. PLOS ONE. 2017;12(5):e0178444. doi: 10.1371/journal.pone.0178444
   Web of Science ®Google Scholar
• Bonzano S, Crisci I, Podlesny-Drabiniok A, et al. Neuron-astroglia cell fate decision in the adult mouse hippocampal neurogenic niche is cell-intrinsically controlled by COUP-TFI in vivo. Cell Rep. 2018;24(2):329–341. doi: 10.1016/j.celrep.2018.06.044
   Web of Science ®Google Scholar
• Xu M, Qin J, Tsai SY, et al. The role of the orphan nuclear receptor COUP-TFII in tumorigenesis. Acta Pharmacol Sin. 2015;36(1):32–36. doi: 10.1038/aps.2014.86
   PubMed Web of Science ®Google Scholar
• Liu Y, Chen S, Cai K, et al. Hypoxia-induced long noncoding RNA NR2F1-AS1 maintains pancreatic cancer proliferation, migration, and invasion by activating the NR2F1/AKT/mTOR axis. Cell Death Dis. 2022;13(3):232. doi: 10.1038/s41419-022-04669-0
   PubMed Web of Science ®Google Scholar
• Sosa MS, Parikh F, Maia AG, et al. NR2F1 controls tumour cell dormancy via SOX9- and RARβ-driven quiescence programmes. Nat Commun. 2015;6(1):6170. doi: 10.1038/ncomms7170
   Google Scholar
• Pan M, Shi J, Yin S, et al. The effect and mechanism of LINC00663 on the biological behavior of glioma. Neurochem Res. 2021;46(7):1737–1746. doi: 10.1007/s11064-021-03311-3
   Web of Science ®Google Scholar
• Ding J, Zhao J, Huan L, et al. Inflammation-induced long intergenic noncoding RNA (LINC00665) increases malignancy through activating the double-stranded RNA–activated protein kinase/nuclear factor Kappa B pathway in hepatocellular carcinoma. Hepatology. 2020;72(5):1666–1681. doi: 10.1002/hep.31195
   PubMed Web of Science ®Google Scholar
• Zhu Q, Li J, Wu Q, et al. Linc-OIP5 in the breast cancer cells regulates angiogenesis of human umbilical vein endothelial cells through YAP1/Notch/NRP1 signaling circuit at a tumor microenvironment. Biol Res. 2020;53(1):5. doi: 10.1186/s40659-020-0273-0
   PubMed Web of Science ®Google Scholar
• Luo H, Yang L, Liu C, et al. TMPO-AS1/miR-98-5p/EBF1 feedback loop contributes to the progression of bladder cancer. Int J Biochem Cell Biol. 2020;122:105702. doi: 10.1016/j.biocel.2020.105702
   PubMed Web of Science ®Google Scholar
• Fu XD, Liu CY, Liu YL, et al. LINC00261 regulates EBF1 to suppress malignant progression of thyroid cancer. Eur Rev Med Pharmacol Sci. 2021;25(24):7626–7634. doi: 10.26355/eurrev_202112_27609
   Web of Science ®Google Scholar